Sign In to Follow Application
View All Documents & Correspondence

“6 Substituted 2,3,4,5 Tetrahydro 1 H Benzo[D]Azepines As 5 Ht2 C Receptor Agonists”

Abstract: The present invention provides 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines of Formula (I) as selective 5-HT2C receptor agonists for the treatment of 5-HT2C associated disorders including obesity, obsessive/compulsive disorder, depression, and anxiety: where R6 is -C=C-R10, -CH=CR11R11" , or -(C0-C8)alkyl-Ar2 optionally substituted on the alkyl moiety with 1 to 6 fluoro substituents and other substituents are as defined in the specification.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
11 March 2008
Publication Number
35/2016
Publication Type
INA
Invention Field
PHARMACEUTICALS
Status
Email
Parent Application

Applicants

ELI LILLY AND COMPANY
Lilly Corporate Center  City of Indianapolis  State of Indiana 46285  United States of America

Inventors

1. John Gordon ALLEN
5255 Via capote  Newbury Park  California 91320  United States of America
2. Karin BRINER
7649 Pinesprings East Drive  Indianapolis  Indiana 46256  United States of America
3. Anne Marie CAMP
Eli Lilly and Company Limited  Lilly house  Priestly Road  Basingstoke  Hampshire RG24 9NL  United Kingdom
4. Manuel Javier CASES-THOMAS
Eli Lilly and Company Limited  Lilly house  Priestly Road  Basingstoke  Hampshire RG24 9NL  United Kingdom
5. Richard Charles HOYING
8136 Timberwood  Plainfield  Indiana 46168  United States of America
6. Maria Angeles MARTINEZ-GRAU
Lilly S.A.  avenida de la Industria 30  28108 Alcobendas (Madrid)  Spain
7. Michael Phillip MAZANETZ
Eli Lilly and Company Limited  Lilly house  Priestly Road  Basingstoke  Hampshire RG24 9NL  United Kingdom
8. Natalia POKROVSKAIA
202-335 Carnarvon Street  New Westminister  British Columbia V3L 1B9  Canada
9. Richard Edmund RATHMELL
Eli Lilly and Company Limited  Lilly house  Priestly Road  Basingstoke  Hampshire RG24 9NL  United Kingdom
10. Roger Ryan ROTHHAAR
5282 West 775 South Reelsville  Indiana 46171  United States of America
11. Selma SAPMAZ
Eli Lilly and Company Limited  Lilly house  Priestly Road  Basingstoke  Hampshire RG24 9NL  United Kingdom
12. Andrew Caerwyn WILLIAMS
Eli Lilly and Company Limited  Lilly house  Priestly Road  Basingstoke  Hampshire RG24 9NL  United Kingdom

Specification

The neurotransmitter serotonin (5-hydroxytryptamine, 5-HT) has a rich pharmacology arising from a heterogenous population of at least seven receptor classes. The serotonin .....

Documents

Application Documents

# Name Date
1 1039-KOLNP-2008-AbandonedLetter.pdf 2024-06-18
1 Form-5.pdf 2011-10-07
2 1039-KOLNP-2008-FER.pdf 2017-04-13
2 Form-3.pdf 2011-10-07
3 Form-1.pdf 2011-10-07
3 1039-KOLNP-2008-FORM 13.pdf 2017-02-10
4 1039-KOLNP-2008-PCT REQUEST FORM.pdf 2011-10-07
4 1039-KOLNP-2008-(19-02-2014)-CORRESPONDENCE.pdf 2014-02-19
5 1039-KOLNP-2008-PCT PRIORITY DOCUMENT NOTIFICATION.pdf 2011-10-07
5 1039-KOLNP-2008-(19-02-2014)-OTHERS.pdf 2014-02-19
6 1039-KOLNP-2008-PA.pdf 2011-10-07
6 1039-KOLNP-2008-(04-02-2013)-CORRESPONDENCE.pdf 2013-02-04
7 1039-KOLNP-2008-INTERNATIONAL SEARCH REPORT.pdf 2011-10-07
7 1039-KOLNP-2008-(04-02-2013)-OTHERS.pdf 2013-02-04
8 1039-KOLNP-2008-INTERNATIONAL PUBLICATION.pdf 2011-10-07
8 1039-KOLNP-2008-(26-10-2012)-CORRESPONDENCE.pdf 2012-10-26
9 1039-KOLNP-2008-(26-10-2012)-FORM-1.pdf 2012-10-26
9 1039-KOLNP-2008-INTERNATIONAL EXM REPORT.pdf 2011-10-07
10 1039-KOLNP-2008-(21-08-2012)-CORRESPONDENCE.pdf 2012-08-21
10 1039-KOLNP-2008-FORM 5-1.1.pdf 2011-10-07
11 1039-KOLNP-2008-(21-08-2012)-OTHERS.pdf 2012-08-21
11 1039-KOLNP-2008-FORM 3-1.1.pdf 2011-10-07
12 1039-KOLNP-2008-ABSTRACT.pdf 2011-10-07
12 1039-KOLNP-2008-FORM 2.pdf 2011-10-07
13 1039-KOLNP-2008-ASSIGNMENT.pdf 2011-10-07
13 1039-kolnp-2008-form 18.pdf 2011-10-07
14 1039-KOLNP-2008-CLAIMS.pdf 2011-10-07
14 1039-KOLNP-2008-FORM 1-1.1.pdf 2011-10-07
15 1039-KOLNP-2008-CORRESPONDENCE OTHERS 1.2.pdf 2011-10-07
15 1039-KOLNP-2008-DESCRIPTION COMPLETE.pdf 2011-10-07
16 1039-KOLNP-2008-CORRESPONDENCE OTHERS-1.1.pdf 2011-10-07
16 1039-KOLNP-2008-CORRESPONDENCE.pdf 2011-10-07
17 1039-KOLNP-2008-CORRESPONDENCE.pdf 2011-10-07
17 1039-KOLNP-2008-CORRESPONDENCE OTHERS-1.1.pdf 2011-10-07
18 1039-KOLNP-2008-CORRESPONDENCE OTHERS 1.2.pdf 2011-10-07
18 1039-KOLNP-2008-DESCRIPTION COMPLETE.pdf 2011-10-07
19 1039-KOLNP-2008-CLAIMS.pdf 2011-10-07
19 1039-KOLNP-2008-FORM 1-1.1.pdf 2011-10-07
20 1039-KOLNP-2008-ASSIGNMENT.pdf 2011-10-07
20 1039-kolnp-2008-form 18.pdf 2011-10-07
21 1039-KOLNP-2008-ABSTRACT.pdf 2011-10-07
21 1039-KOLNP-2008-FORM 2.pdf 2011-10-07
22 1039-KOLNP-2008-(21-08-2012)-OTHERS.pdf 2012-08-21
22 1039-KOLNP-2008-FORM 3-1.1.pdf 2011-10-07
23 1039-KOLNP-2008-(21-08-2012)-CORRESPONDENCE.pdf 2012-08-21
23 1039-KOLNP-2008-FORM 5-1.1.pdf 2011-10-07
24 1039-KOLNP-2008-INTERNATIONAL EXM REPORT.pdf 2011-10-07
24 1039-KOLNP-2008-(26-10-2012)-FORM-1.pdf 2012-10-26
25 1039-KOLNP-2008-INTERNATIONAL PUBLICATION.pdf 2011-10-07
25 1039-KOLNP-2008-(26-10-2012)-CORRESPONDENCE.pdf 2012-10-26
26 1039-KOLNP-2008-INTERNATIONAL SEARCH REPORT.pdf 2011-10-07
26 1039-KOLNP-2008-(04-02-2013)-OTHERS.pdf 2013-02-04
27 1039-KOLNP-2008-PA.pdf 2011-10-07
27 1039-KOLNP-2008-(04-02-2013)-CORRESPONDENCE.pdf 2013-02-04
28 1039-KOLNP-2008-PCT PRIORITY DOCUMENT NOTIFICATION.pdf 2011-10-07
28 1039-KOLNP-2008-(19-02-2014)-OTHERS.pdf 2014-02-19
29 1039-KOLNP-2008-PCT REQUEST FORM.pdf 2011-10-07
29 1039-KOLNP-2008-(19-02-2014)-CORRESPONDENCE.pdf 2014-02-19
30 Form-1.pdf 2011-10-07
30 1039-KOLNP-2008-FORM 13.pdf 2017-02-10
31 1039-KOLNP-2008-FER.pdf 2017-04-13
31 Form-3.pdf 2011-10-07
32 1039-KOLNP-2008-AbandonedLetter.pdf 2024-06-18
32 Form-5.pdf 2011-10-07

Search Strategy

1 SEARCHREPORT_31-03-2017.pdf